Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Other Non-Current Assets (2017 - 2025)

Fresenius Medical Care AG has reported Other Non-Current Assets over the past 16 years, most recently at $254.0 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $254.0 million for Q4 2025, down 70.13% from a year ago — trailing twelve months through Dec 2025 was $254.0 million (down 70.13% YoY), and the annual figure for FY2025 was $254.0 million, down 70.13%.
  • Other Non-Current Assets for Q4 2025 was $254.0 million at Fresenius Medical Care AG, down from $850.4 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for FMCQF hit a ceiling of $1.1 billion in Q4 2021 and a floor of $23.3 million in Q4 2022.
  • Median Other Non-Current Assets over the past 5 years was $254.0 million (2025), compared with a mean of $485.2 million.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 97.8% in 2022 and later skyrocketed 932.54% in 2023.
  • Fresenius Medical Care AG's Other Non-Current Assets stood at $1.1 billion in 2021, then tumbled by 97.8% to $23.3 million in 2022, then skyrocketed by 932.54% to $240.6 million in 2023, then surged by 253.54% to $850.4 million in 2024, then crashed by 70.13% to $254.0 million in 2025.
  • The last three reported values for Other Non-Current Assets were $254.0 million (Q4 2025), $850.4 million (Q4 2024), and $240.6 million (Q4 2023) per Business Quant data.